| |
| |
|
| Insider
Information: |
Mccarthy Sean A. |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
634,249 |
|
|
Indirect Shares
|
93,158 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
727,407 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytomx Therapeutics, Inc. |
CTMX |
|
2024-03-26 |
634,249 |
2024-03-26 |
93,158 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2024-03-26 |
4 |
OE |
$1.57 |
$172,874 |
D/D |
109,768 |
634,249 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2024-03-19 |
4 |
S |
$2.09 |
$42,175 |
D/D |
(20,223) |
524,481 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
544,704 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2023-12-20 |
4 |
S |
$1.38 |
$18,710 |
D/D |
(13,551) |
454,704 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2023-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
468,255 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2023-09-22 |
4 |
S |
$1.30 |
$18,987 |
D/D |
(14,601) |
430,755 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2023-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
445,356 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2023-05-19 |
4 |
OE |
$1.57 |
$26,041 |
D/D |
16,535 |
405,356 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2023-03-16 |
4 |
S |
$1.88 |
$13,391 |
D/D |
(7,121) |
388,821 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
CEO |
• • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
395,942 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2022-07-20 |
4 |
S |
$1.42 |
$21,206 |
D/D |
(14,911) |
290,942 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2022-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
305,853 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2022-05-09 |
4 |
OE |
$0.95 |
$85,930 |
D/D |
90,931 |
265,853 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
174,922 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2021-08-11 |
4 |
OE |
$1.13 |
$104,447 |
D/D |
92,113 |
99,922 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2021-06-16 |
4 |
AS |
$7.04 |
$704,470 |
I/I |
(100,000) |
93,118 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2021-03-31 |
4 |
AS |
$7.49 |
$749,470 |
D/D |
(100,000) |
206,894 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2021-03-31 |
4 |
OE |
$1.13 |
$113,390 |
D/D |
100,000 |
306,894 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2020-12-23 |
4 |
OE |
$1.13 |
$113,390 |
D/D |
100,000 |
206,894 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2020-11-30 |
4 |
A |
$6.39 |
$5,945 |
D/D |
930 |
106,894 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2020-09-21 |
4 |
OE |
$6.61 |
$135,601 |
D/D |
20,500 |
105,964 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2020-05-29 |
4 |
A |
$5.11 |
$5,916 |
D/D |
1,158 |
85,464 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2020-05-12 |
4 |
OE |
$1.13 |
$40,820 |
D/D |
36,000 |
120,306 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2020-05-12 |
4 |
AS |
$15.00 |
$540,000 |
D/D |
(36,000) |
84,306 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2019-11-30 |
4 |
A |
$5.32 |
$5,747 |
D/D |
1,080 |
84,306 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
